spring hay fever
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: who can participate with written consent, who is applicable for H1-antagonist treatment, who has spring hay fever, who is outpatient.
Exclusion criteria
Exclusion criteria: who is not apllicable for H1 antagonist, who may need systemin steroid treatment, who plans to apply hyposensitization therapy or surgical procedures at the time of consent, who is under the medication which affects to daytime sleepness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| global assessment of Rtime operationality | — |
Secondary
| Measure | Time frame |
|---|---|
| drug compliance, follow rate, sleepness score, global assessment of symptom, consent rate | — |
Countries
Japan